Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.370
-0.160 (-6.32%)
At close: May 8, 2026, 4:00 PM EDT
2.340
-0.030 (-1.27%)
After-hours: May 8, 2026, 7:22 PM EDT
Organogenesis Holdings Employees
Organogenesis Holdings had 854 employees as of December 31, 2025. The number of employees decreased by 15 or -1.73% compared to the previous year.
Employees
854
Change (1Y)
-15
Growth (1Y)
-1.73%
Revenue / Employee
$602,698
Profits / Employee
-$17,033
Market Cap
304.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 854 | -15 | -1.73% |
| Dec 31, 2024 | 869 | 7 | 0.81% |
| Dec 31, 2023 | 862 | -168 | -16.31% |
| Dec 31, 2022 | 1,030 | 80 | 8.42% |
| Dec 31, 2021 | 950 | 40 | 4.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Kamada | 462 |
| Evolus | 350 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
ORGO News
- 1 day ago - Organogenesis downgraded to Neutral from Buy at BTIG - TheFly
- 2 days ago - Organogenesis Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 2 days ago - Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 11 days ago - Organogenesis completes rolling submission of ReNu BLA - TheFly
- 11 days ago - Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® - GlobeNewsWire
- 4 weeks ago - Why is Organogenesis Stock (ORGO) Up 20% Today? - TipRanks
- 4 weeks ago - Organogenesis achieves primary endpoint in PuraPly study - TheFly
- 4 weeks ago - Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM - GlobeNewsWire